Metabolic Profiling of Type 2 Diabetes Patients after Bariatric Surgery by Raman Spectroscopy

Background: Bariatric surgery (BS) is an important procedure used for the treatment of morbid obesity and has been proven to improve, or even cure, type 2 diabetes mellitus (T2DM). However, of the patients with T2DM who initially go into remission, a proportion experience a relapse during the follow...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Arianna Bonizzi, Marta Sevieri, Leopoldo Sitia, Andrea Rizzi, Lorenzo Conti, Fabio Corsi, Carlo Morasso, Serena Mazzucchelli
Formato: article
Lenguaje:EN
Publicado: MDPI AG 2021
Materias:
T
Acceso en línea:https://doaj.org/article/2ae3cd64bfdc4f9f81bddab45e228d05
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:2ae3cd64bfdc4f9f81bddab45e228d05
record_format dspace
spelling oai:doaj.org-article:2ae3cd64bfdc4f9f81bddab45e228d052021-11-25T16:35:57ZMetabolic Profiling of Type 2 Diabetes Patients after Bariatric Surgery by Raman Spectroscopy10.3390/app1122107102076-3417https://doaj.org/article/2ae3cd64bfdc4f9f81bddab45e228d052021-11-01T00:00:00Zhttps://www.mdpi.com/2076-3417/11/22/10710https://doaj.org/toc/2076-3417Background: Bariatric surgery (BS) is an important procedure used for the treatment of morbid obesity and has been proven to improve, or even cure, type 2 diabetes mellitus (T2DM). However, of the patients with T2DM who initially go into remission, a proportion experience a relapse during the follow-up. In this context, Raman spectroscopy (RS) could be a promising technique for monitoring the metabolic profile of patients after surgical treatment with the aim of improving their postsurgical management. Methods: Fourteen obese patients with T2DM were recruited. Clinical parameters, adipokines, ghrelin, Fibroblast growth factor 19 (FGF-19) values, and Raman spectra were collected and analyzed before and after surgery. RS results were compared with profiles obtained from 23 healthy subjects (HC), to observe whether the metabolic fingerprint of bariatric patients normalized during the surgical follow-up. Results: The reduction in anthropometric measures and improved glycemic control and lipid profile after surgical treatment highlighted the benefits of BS. Consequently, adipokines, ghrelin and FGF-19 concentration returned to normal values after surgery. However, RS data highlighted an altered metabolic profile even after BS. Conclusion: RS suggests that BS does not fully restore the metabolic profile of patients in the immediate follow-up after the surgery.Arianna BonizziMarta SevieriLeopoldo SitiaAndrea RizziLorenzo ContiFabio CorsiCarlo MorassoSerena MazzucchelliMDPI AGarticletype 2 diabetes mellitusobesitybariatric surgeryremissionRaman spectroscopyTechnologyTEngineering (General). Civil engineering (General)TA1-2040Biology (General)QH301-705.5PhysicsQC1-999ChemistryQD1-999ENApplied Sciences, Vol 11, Iss 10710, p 10710 (2021)
institution DOAJ
collection DOAJ
language EN
topic type 2 diabetes mellitus
obesity
bariatric surgery
remission
Raman spectroscopy
Technology
T
Engineering (General). Civil engineering (General)
TA1-2040
Biology (General)
QH301-705.5
Physics
QC1-999
Chemistry
QD1-999
spellingShingle type 2 diabetes mellitus
obesity
bariatric surgery
remission
Raman spectroscopy
Technology
T
Engineering (General). Civil engineering (General)
TA1-2040
Biology (General)
QH301-705.5
Physics
QC1-999
Chemistry
QD1-999
Arianna Bonizzi
Marta Sevieri
Leopoldo Sitia
Andrea Rizzi
Lorenzo Conti
Fabio Corsi
Carlo Morasso
Serena Mazzucchelli
Metabolic Profiling of Type 2 Diabetes Patients after Bariatric Surgery by Raman Spectroscopy
description Background: Bariatric surgery (BS) is an important procedure used for the treatment of morbid obesity and has been proven to improve, or even cure, type 2 diabetes mellitus (T2DM). However, of the patients with T2DM who initially go into remission, a proportion experience a relapse during the follow-up. In this context, Raman spectroscopy (RS) could be a promising technique for monitoring the metabolic profile of patients after surgical treatment with the aim of improving their postsurgical management. Methods: Fourteen obese patients with T2DM were recruited. Clinical parameters, adipokines, ghrelin, Fibroblast growth factor 19 (FGF-19) values, and Raman spectra were collected and analyzed before and after surgery. RS results were compared with profiles obtained from 23 healthy subjects (HC), to observe whether the metabolic fingerprint of bariatric patients normalized during the surgical follow-up. Results: The reduction in anthropometric measures and improved glycemic control and lipid profile after surgical treatment highlighted the benefits of BS. Consequently, adipokines, ghrelin and FGF-19 concentration returned to normal values after surgery. However, RS data highlighted an altered metabolic profile even after BS. Conclusion: RS suggests that BS does not fully restore the metabolic profile of patients in the immediate follow-up after the surgery.
format article
author Arianna Bonizzi
Marta Sevieri
Leopoldo Sitia
Andrea Rizzi
Lorenzo Conti
Fabio Corsi
Carlo Morasso
Serena Mazzucchelli
author_facet Arianna Bonizzi
Marta Sevieri
Leopoldo Sitia
Andrea Rizzi
Lorenzo Conti
Fabio Corsi
Carlo Morasso
Serena Mazzucchelli
author_sort Arianna Bonizzi
title Metabolic Profiling of Type 2 Diabetes Patients after Bariatric Surgery by Raman Spectroscopy
title_short Metabolic Profiling of Type 2 Diabetes Patients after Bariatric Surgery by Raman Spectroscopy
title_full Metabolic Profiling of Type 2 Diabetes Patients after Bariatric Surgery by Raman Spectroscopy
title_fullStr Metabolic Profiling of Type 2 Diabetes Patients after Bariatric Surgery by Raman Spectroscopy
title_full_unstemmed Metabolic Profiling of Type 2 Diabetes Patients after Bariatric Surgery by Raman Spectroscopy
title_sort metabolic profiling of type 2 diabetes patients after bariatric surgery by raman spectroscopy
publisher MDPI AG
publishDate 2021
url https://doaj.org/article/2ae3cd64bfdc4f9f81bddab45e228d05
work_keys_str_mv AT ariannabonizzi metabolicprofilingoftype2diabetespatientsafterbariatricsurgerybyramanspectroscopy
AT martasevieri metabolicprofilingoftype2diabetespatientsafterbariatricsurgerybyramanspectroscopy
AT leopoldositia metabolicprofilingoftype2diabetespatientsafterbariatricsurgerybyramanspectroscopy
AT andrearizzi metabolicprofilingoftype2diabetespatientsafterbariatricsurgerybyramanspectroscopy
AT lorenzoconti metabolicprofilingoftype2diabetespatientsafterbariatricsurgerybyramanspectroscopy
AT fabiocorsi metabolicprofilingoftype2diabetespatientsafterbariatricsurgerybyramanspectroscopy
AT carlomorasso metabolicprofilingoftype2diabetespatientsafterbariatricsurgerybyramanspectroscopy
AT serenamazzucchelli metabolicprofilingoftype2diabetespatientsafterbariatricsurgerybyramanspectroscopy
_version_ 1718413066658381824